miRNA‐143 replacement therapy harnesses the proliferation and migration of colorectal cancer cells in vitro

miRNA‐143 replacement therapy harnesses the proliferation and migration of colorectal cancer cells in vitro


چاپ صفحه
پژوهان
صفحه نخست سامانه
چکیده مقاله
چکیده مقاله
نویسندگان
نویسندگان
دانلود مقاله
دانلود مقاله
دانشگاه علوم پزشکی تبریز
دانشگاه علوم پزشکی تبریز

نویسندگان: طاهره زینلی , نیر حسین اهلی , بهزاد منصوری , علی محمدی , مهدی یوسفی , میلاد اسدی , صنم صدرالدینی , داریوش شانه بندی , بهزاد برادران

کلمات کلیدی: apoptosis, colorectal cancer, metastasis, microRNA replacement therapy, miR‐143 restoration

نشریه: 19614 , 2019 , 2019 , 2019

اطلاعات کلی مقاله
hide/show

نویسنده ثبت کننده مقاله بهزاد برادران
مرحله جاری مقاله تایید نهایی
دانشکده/مرکز مربوطه مرکز تحقیقات ایمونولوژی
کد مقاله 66597
عنوان فارسی مقاله miRNA‐143 replacement therapy harnesses the proliferation and migration of colorectal cancer cells in vitro
عنوان لاتین مقاله miRNA‐143 replacement therapy harnesses the proliferation and migration of colorectal cancer cells in vitro
ناشر 9
آیا مقاله از طرح تحقیقاتی و یا منتورشیپ استخراج شده است؟ بلی
عنوان نشریه (خارج از لیست فوق)
نوع مقاله Original Article
نحوه ایندکس شدن مقاله ایندکس شده سطح یک – ISI - Web of Science
آدرس لینک مقاله/ همایش در شبکه اینترنت

خلاصه مقاله
hide/show

miR‐143 is a tumor suppressor miRNA which its downregulation is frequently reported in colorectal cancer (CRC). This miRNA is a negative regulator of K‐RAS, c‐MYC, BCL‐2, and MMP‐9 genes which are engaged in tumor growth and metastasis. In the present study, miR‐143 restoration was performed by transfection of the pCMV‐miR‐143 vector into the SW‐480 CRC cells. Subsequently, alterations in proliferative and migratory potential of the cells were investigated by the 3‐(4,5‐dimethylthiazol‐2‐yl)‐2,5‐diphenyl tetrazolium bromide (MTT) and wound‐healing assays, respectively. Moreover, to detect apoptosis incidence in the transfected cells, 4',6‐diamidino‐2‐phenylindole (DAPI) staining was used. Furthermore, mRNA levels of c‐MYC, K‐RAS, MMP‐9, and BCL‐2, as potential targets of miR‐143, were assessed by quantitative Real‐Time PCR (qRT‐PCR). Also the expression levels of c‐MYC, K‐RAS, and MMP‐9 proteins were investigated by the western blot analysis. Finally, the ratio of BAX to BCL‐2 expression, as a potential marker of the response to apoptosis stimuli, was compared between the control and test groups. Furthermore, the trypan blue test was performed to determine the cell viability in cell suspension. According to the results, a decreased viability and migratory potential was observed for the miR‐143 receiving cells. The DAPI staining also confirmed the occurrence of apoptosis. Moreover, BCL‐2, K‐RAS, MMP‐9, and c‐MYC mRNAs were significantly downregulated in the miR‐143 grafted cells. The BAX/BCL‐2 ratio also indicated a notable increase in the cells with miR‐143 overexpression. In brief, miR‐143 replacement could be considered as an effective strategy for the management of CRC and attenuating its invasive features.

نویسندگان
hide/show

نویسنده نفر چندم مقاله
طاهره زینلیدوم
نیر حسین اهلیسوم
بهزاد منصوریچهارم
علی محمدیپنجم
مهدی یوسفیششم
میلاد اسدیهفتم
صنم صدرالدینیهشتم
داریوش شانه بندیدهم
بهزاد برادراننهم

لینک دانلود مقاله
hide/show

نام فایل تاریخ درج فایل اندازه فایل دانلود
miRNA 143 replacement therapy harnesses the proliferation.pdf1398/02/09856415دانلود